Lars Blumenstein
Impact in
- Molecular Biology top 10%
- Protein Kinase Regulation and GTPase Signaling
- PI3K/AKT/mTOR signaling in cancer
- Protein Structure and Dynamics
-
- Cancer Genomics and Diagnostics
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 7
- PI3K/AKT/mTOR signaling in cancer 4
-
- Amino Acid Enzymes and Metabolism 2
- Co-authors
- Mohammad Reza Ahmadian (8 shared papers)Radovan Dvorský (5 shared papers)Ingrid R. Vetter (4 shared papers)David Demanse (4 shared papers)Douglas Bootle (4 shared papers)Cornelia Quadt (4 shared papers)Martin Schüler (3 shared papers)Howard A. Burris (3 shared papers)
- Journals
- Biochemistry (4 papers)Journal of Nuclear Medicine (3 papers)Journal of Biological Chemistry (3 papers)FEBS Letters (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Lars Blumenstein
29 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 532
- Cancer Research 59
- Pharmaceutical Science 31
- Biochemistry 16
- Pulmonary and Respiratory Medicine 111
Countries citing papers authored by Lars Blumenstein
This map shows the geographic impact of Lars Blumenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Blumenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Blumenstein more than expected).
Fields of papers citing papers by Lars Blumenstein
This network shows the impact of papers produced by Lars Blumenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Blumenstein. The network helps show where Lars Blumenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Blumenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 358 | |
| 2 | 2018 | 216 | |
| 3 | 2004 | 131 | |
| 4 | 2004 | 119 | |
| 5 | 2004 | 66 | |
| 6 | 2003 | 65 | |
| 7 | 2007 | 61 | |
| 8 | 2007 | 52 | |
| 9 | 2008 | 48 | |
| 10 | 2021 | 45 | |
| 11 | 2023 | 44 | |
| 12 | 2015 | 35 | |
| 13 | 2002 | 32 | |
| 14 | 2006 | 28 | |
| 15 | 2004 | 24 | |
| 16 | 2007 | 24 | |
| 17 | 2021 | 24 | |
| 18 | 2020 | 19 | |
| 19 | 2025 | 16 | |
| 20 | 2023 | 12 |
About Lars Blumenstein
Lars Blumenstein is a scholar working on Molecular Biology, Biochemistry, Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging and Otorhinolaryngology, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (7 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Advanced Breast Cancer Therapies (2 papers), Drug Solubulity and Delivery Systems (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Amino Acid Enzymes and Metabolism (2 papers), Synthesis and biological activity (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Molecular Biology (532 citations), Cancer Research (59 citations), Pharmaceutical Science (31 citations), Biochemistry (16 citations) and Pulmonary and Respiratory Medicine (111 citations). Lars Blumenstein has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Mohammad Reza Ahmadian, Radovan Dvorský, Ingrid R. Vetter, David Demanse, Douglas Bootle, Cornelia Quadt, Martin Schüler, Howard A. Burris, José Baselga and Marta Gil-Martín. Their work appears in journals such as Biochemistry, Journal of Nuclear Medicine, Journal of Biological Chemistry, FEBS Letters and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.